General Information
Application | Inhibitor |
---|
Description | Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity. |
---|
Cas NO. |
1129403-56-0 |
---|
Purity | ≥98% |
---|---|
Molecular Weight | 539.69 |
Formula | C31H33N5O2S |
Solubility |
DMSO : 14 mg/mL Ethanol : 1 mg/mL Water : Insoluble |
---|
Target / IC50 |
Nanog |
---|
Storage |
Powder : -20°C for 3 years Solvent : -80°C for 6 months |
---|
Alias |
BBI503 |
---|
|
1 mg |
5 mg |
10 mg |
|
1 mM |
1.8529 mL | 9.2646 mL | 18.5292 mL | |
5 mM | 0.3706 mL | 1.8529 mL | 3.7058 mL | |
10 mM | 0.1853 mL | 0.9265 mL | 1.8529 mL |